Clear market notes built around the JSE, the rand, and what matters locally.

2026-07-19 00:30 • The Motley Fool Positive Axe Cap view: Selective

Chubb, the world's largest publicly traded property and casualty insurer, trades at a 12x P/E ratio compared to the S&P 500's 32x multiple, suggesting potential undervaluation. The company has delivered 226% total returns over the past decade and expects continued growth through middle-market expansion, AI upgrades, and higher fixed-income yields. With a 33-year dividend increase streak and a $7.5 billion buyback authorization, Chubb appears to be a stable, defensive investment opportunity.

Axe note: Chubb trades at a low multiple with steady dividends and growth prospects, presenting a rare value in insurance.

2026-07-19 00:16 • The Motley Fool Positive Axe Cap view: Selective

The article compares two healthcare ETFs: IHE (U.S. Pharmaceuticals) and IXJ (Global Healthcare). IHE offers concentrated exposure to 56 U.S. pharmaceutical companies with higher recent returns (50.30% 1-yr), but carries significant concentration risk with its top two holdings (J&J and Eli Lilly) comprising 43% of the portfolio. IXJ provides broader diversification across 110 international healthcare companies including medical devices and services, with lower concentration risk but more modest recent returns (18.20% 1-yr). The article suggests IXJ is better for diversification-focused investors, while IHE's outperformance is largely driven by GLP-1 weight-loss drug success.

Axe note: Comparing concentrated U.S. pharma ETF IHE against diversified global healthcare ETF IXJ through a South African lens.

2026-07-18 22:30 • The Motley Fool Positive Axe Cap view: Selective

SpaceX could deliver a 10x return if annual revenue reaches $3.6 trillion by 2040, aligning with Morgan Stanley's $3.4 trillion projection. Currently trading at $1.8 trillion market cap with $18.7 billion in 2025 revenue, the company would need a 5x price-to-sales ratio to reach an $18 trillion valuation. However, this scenario depends on successful execution of Starlink, Starship, and AI segments, with significant downside risk if any underperforms.

Axe note: SpaceX’s potential 10x gains hinge on moonshot execution, but South African investors should watch USD/ZAR first.